CATEEHAR Trademark

Trademark Overview


On Thursday, July 13, 2023, a trademark application was filed for CATEEHAR with the United States Patent and Trademark Office. The USPTO has given the CATEEHAR trademark a serial number of 98083782. The federal status of this trademark filing is REGISTERED as of Tuesday, May 13, 2025. This trademark is owned by Advenchen Pharmaceuticals, LLC. The CATEEHAR trademark is filed in the Pharmaceutical Products category with the following description:

chemical preparations and reagents for pharmaceutical, medical, and clinical purposes, namely, for the prevention and treatment of cancer or combination treatment of multiple cancers; pharmaceuticals, pharmaceutical preparations and substances for the prevention and treatment of cancer(s)
cateehar

General Information


Serial Number98083782
Word MarkCATEEHAR
Filing DateThursday, July 13, 2023
Status700 - REGISTERED
Status DateTuesday, May 13, 2025
Registration Number7796325
Registration DateTuesday, May 13, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2024

Trademark Statements


Goods and Serviceschemical preparations and reagents for pharmaceutical, medical, and clinical purposes, namely, for the prevention and treatment of cancer or combination treatment of multiple cancers; pharmaceuticals, pharmaceutical preparations and substances for the prevention and treatment of cancer(s)

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, August 13, 2023
Primary Code005
First Use Anywhere DateWednesday, December 11, 2024
First Use In Commerce DateWednesday, December 11, 2024

Trademark Owner History


Party NameAdvenchen Pharmaceuticals, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressMoorpark, CA 93021

Party NameAdvenchen Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMoorpark, CA 93021

Party NameAdvenchen Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMoorpark, CA 93021

Trademark Events


Event DateEvent Description
Monday, July 17, 2023NEW APPLICATION ENTERED
Sunday, August 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 21, 2024ASSIGNED TO EXAMINER
Thursday, March 21, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 18, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, December 12, 2024SOU EXTENSION 1 FILED
Thursday, December 12, 2024USE AMENDMENT FILED
Thursday, December 12, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, December 12, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 25, 2025STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 25, 2025SOU EXTENSION 1 GRANTED
Thursday, March 6, 2025ASSIGNED TO EXAMINER
Friday, March 7, 2025NON-FINAL ACTION E-MAILED
Tuesday, February 25, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 26, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 7, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 7, 2025SU - NON-FINAL ACTION - WRITTEN
Tuesday, April 15, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 15, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 15, 2025ASSIGNED TO LIE
Wednesday, April 23, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 13, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, May 13, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, April 23, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, March 26, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED